Catapano Joseph Ronald 4

What Happened

• Joseph Ronald Catapano, Chief Accounting Officer of Teladoc Health (TDOC), had performance stock units and restricted stock units convert to shares on June 1, 2026 (derivative conversions). The filings show conversions of 39 shares and 833 shares (total 872 shares). Some of those converted shares were treated as dispositions at $0.00 (derivative-related withholding), and on June 2, 2026 he sold 284 shares in the open market at $7.63 per share, receiving $2,166. These transactions are routine and appear to be related to tax withholding following vesting rather than a market-timing purchase.

Key Details

• Transaction dates and prices:
  • 2026-06-01: Conversion/exercise of derivative awards — 39 shares and 833 shares (reported at $0.00 for the dispositions related to withholding).
  • 2026-06-02: Open-market sale — 284 shares at $7.63, proceeds $2,166.
• Footnotes:
  • F1/F2: PSUs and RSUs convert one-for-one to common shares.
  • F3: Shares sold/withheld to cover tax withholding for vesting of PSUs and RSUs.
  • F4/F5: Provide grant and vesting background (PSU earned 3/1/2026; 10,000 RSU grant 3/1/2025 with staged vesting).
• Shares owned after transaction: Not specified in the Form 4 filing.
• Filing timeliness: Form 4 filed 2026-06-03 for transactions dated 6/1–6/2/2026 — appears timely (filed within required reporting window).

Context

• These were conversions of vested equity awards (PSUs/RSUs), not open-market purchases. Some converted shares were withheld or otherwise surrendered (reported as $0 dispositions) and a small block (284 shares) was sold in the open market to satisfy tax obligations. Such transactions are commonly administrative (tax withholding) rather than a direct signal of insider bullish/bearish trading.